INTS Chart
See on advanced chart >
About
Intensity Therapeutics, Inc. was incorporated in Delaware on November 30, 2012. The company is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRx technology platform to...
Read More
- HighlightA clinical-stage biotechnology company whose treatment approach addresses both the regional and systemic nature of a patient’s cancer.
- ExchangeNASDAQ
- Listing Date06/30/2023
- Established Date11/30/2012
- Full-time Employees5
- Address1 Enterprise Drive Suite 430 Shelton CT 06484-4779
- Tel1-203-2217381
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology